These initial studies establish miR-21’s role in promoting colon cancer cell invasion and survival, potentially through targets like TIMP3/RECK and modulation of the PI3K/Akt pathway, suggesting inhibitors like Celastrol could counteract its effects. The gene discussed is AKT1; the disease is malignant colon neoplasm.